Science News Review

Ebola Vaccines Successful in Primates

Mar 31 at 8:08pm by Aileen

Soon to enter human trials

The US Centers for Disease Control and Prevention is reporting this week that researchers from the US and Canada have successfully tested several vaccines for Ebola in primates, and are now seeking to modify them for human use.

This is a significant development not because Ebola in its natural habitat is such a grave danger to humanity, but because it’s got a 90% fatality rate and thus represents a threat to humanity as a bioweapon. While Ebola is not easily spread (direct contact with bodily fluids of an infected person or animal is required), officials have long been concerned that it could be “weaponized” – as has been done with anthrax, for instance – into a form that will be easily infective. There have been just over 1500 documented cases of Ebola in humans, and so far it does not seem to have been used as a bioweapon.

The Federation of American Scientists maintains an Ebola Fact Sheet indicating that the Soviet Union probably investigated weaponizing Ebola. There have been three reported incidents of researchers being infected after being stuck with contaminated syringes. Those in England and the U.S. recovered, one in Russia died. There is no effective treatment for the disease, and while the current research is hopeful, there is no vaccine to prevent it.

The biosafety threat level for Ebola is 4, a rating it shares with the 18 other hemorrhagic fevers it is akin to. Because the dead virus does not produce an effective immune response, researchers have been trying several different recombinant DNA techniques. The latest, most effective candidates are soon to be tested on humans. It is hoped that if the testing proves successful, the techniques will be as useful in developing vaccines for other hemorrhagic fever viruses, HIV and avian influenza.

Links:

Vaccine for Ebola Virus Successful in Primates
Ebola Fact Sheet